Hinweis nach § 34 des WpHG zur Begründung möglicher Interessenskonflikte:
Meine Beiträge stellen weder Kauf- oder Verkaufsempfehlungen dar
Die grösste Entscheidung deines Lebens liegt darin dass du dein Leben ändern kannst,
indem du deine Geisteshaltung änderst (Albert Schweitzer)
Hinweis nach §34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser von o.g. Beitrag kann Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n) halten. Entsprechende Beiträge stellen keine Kauf- oder Verkaufsempfehlungen dar.
Hinweis nach §34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser von o.g. Beitrag kann Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n) halten. Entsprechende Beiträge stellen keine Kauf- oder Verkaufsempfehlungen dar.
hat sich halbiert die Tage und restliche Cannabis Butzen bis zu 40% vom Tief wieder up
Hinweis nach § 34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser dieses Beitrags hält jetzt oder zukünftig Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n).
Hinweis nach § 34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser dieses Beitrags kann Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n) halten. Entsprechende Beiträge stellen keine Kauf- oder Verkaufsempfehlungen dar.
Also In the News (C-ACB) Aurora Cannabis Inc
Also In the News (C-CMED) CanniMed Therapeutics Inc
The Financial Post reports in its Wednesday, Jan. 17, edition that on Wednesday, Newstrike Resources will vote on whether to merge with CanniMed Therapeutics. The Post's Mark Rendell writes that CanniMed shareholders will vote on the same deal the following Tuesday. CanniMed has been locked in a battle with Aurora Cannabis, which is trying to take over CanniMed in a deal that is contingent on the Newstrike merger being rejected. Both Newstrike chief executive officer Jay Wilgar and CanniMed CEO Brent Zettl are urging shareholder support for the merger plan, which they say has been in the works since October. The main stumbling block, however, in Wednesday's vote could be Newstrike's share price, which shot up from 64 cents on Jan. 2 to $2.95 on Jan. 9, before dropping back down to $1.34 by Tuesday. PI Financial analyst Jason Zandberg says: "With the way the multiples work, Newstrike is now worth more than CanniMed. I believe it's a 65, 35 merger, so (Newstrike shares) would be worth almost half in that transaction." Mr. Wilgar is hoping his company's shareholders look past the short- term moves in the market, which have made Newstrike investors richer but the merger with CanniMed less attractive.
Also In the News (C-ACB) Aurora Cannabis Inc
Also In the News (C-CMED) CanniMed Therapeutics Inc
The Financial Post reports in its Wednesday, Jan. 17, edition that on Wednesday, Newstrike Resources will vote on whether to merge with CanniMed Therapeutics. The Post's Mark Rendell writes that CanniMed shareholders will vote on the same deal the following Tuesday. CanniMed has been locked in a battle with Aurora Cannabis, which is trying to take over CanniMed in a deal that is contingent on the Newstrike merger being rejected. Both Newstrike chief executive officer Jay Wilgar and CanniMed CEO Brent Zettl are urging shareholder support for the merger plan, which they say has been in the works since October. The main stumbling block, however, in Wednesday's vote could be Newstrike's share price, which shot up from 64 cents on Jan. 2 to $2.95 on Jan. 9, before dropping back down to $1.34 by Tuesday. PI Financial analyst Jason Zandberg says: "With the way the multiples work, Newstrike is now worth more than CanniMed. I believe it's a 65, 35 merger, so (Newstrike shares) would be worth almost half in that transaction." Mr. Wilgar is hoping his company's shareholders look past the short- term moves in the market, which have made Newstrike investors richer but the merger with CanniMed less attractive.
Hinweis nach § 34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser dieses Beitrags kann Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n) halten. Entsprechende Beiträge stellen keine Kauf- oder Verkaufsempfehlungen dar.
Zuletzt bearbeitet von Paradiso am 17.01.2018, 15:38, insgesamt einmal bearbeitet
heute 2 Position mit Schnitt 0,77 gesammelt. Vor paar Tagen noch bei 2,25 .
Hier könnte ein fetter Rebound anstehen!!Hinweis nach § 34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser dieses Beitrags hält jetzt oder zukünftig Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n).
Jetzt müsste Aurora Newstrike übernehmen ... also sogar noch Übernahmephantasie in Newstrike!
Meinungen?
Newstrike receives shareholder OK for CanniMed deal
2018-01-17 16:06 ET - News Release
An anonymous director reports
NEWSTRIKE ANNOUNCES SHAREHOLDER APPROVAL OF PLAN OF ARRANGEMENT WITH CANNIMED
At an annual and special meeting of shareholders held today, Newstrike Resources Ltd.'s shareholders overwhelmingly approved the previously announced proposed plan of arrangement with CanniMed Therapeutics Inc. pursuant to which CanniMed will acquire all of the outstanding common shares of Newstrike. Of those votes cast with respect to the Plan of Arrangement, an aggregate of 271,880,416 Common Shares, representing approximately 99.40% of the votes cast by the shareholders at the Meeting or represented by proxy, were voted in support of the resolution. In addition, an aggregate of 239,517,680 Common Shares, representing approximately 99.30% of the votes cast by the shareholders at the meeting or represented by proxy excluding certain insiders, were voted in support of the resolution.
In addition to the foregoing, all other matters voted upon at the Meeting by shareholders were approved, including the election of all nominated directors, the appointment of the Company's auditor, and the confirmation of Newstrike's existing stock option plan.
The Plan of Arrangement remains subject to approval of the shareholders of CanniMed at a special meeting of shareholders which is currently scheduled for Tuesday, January 23, 2018, court approval, applicable regulatory approvals, and the satisfaction of certain other closing conditions customary in transactions of this nature, as specified in the Company's management information circular dated December 12, 2017, available on SEDAR at www.sedar.com.
About Newstrike
Newstrike is the parent company of Up Cannabis Inc., a licensed producer of cannabis that received its cultivation license on December 19, 2016, and was granted an amendment to begin sales on January 5, 2018. Up Cannabis is in turn the parent company of Up Cannabis Niagara Inc. Newstrike, together with its strategic partners, including Canada's iconic musicians The Tragically Hip, is developing a diverse network of high quality cannabis brands. For more information visit www.up.ca or www.newstrike.ca
Jetzt müsste Aurora Newstrike übernehmen ... also sogar noch Übernahmephantasie in Newstrike!
Meinungen?
Newstrike receives shareholder OK for CanniMed deal
2018-01-17 16:06 ET - News Release
An anonymous director reports
NEWSTRIKE ANNOUNCES SHAREHOLDER APPROVAL OF PLAN OF ARRANGEMENT WITH CANNIMED
[...]
Hinweis nach § 34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser dieses Beitrags hält jetzt oder zukünftig Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n).
Jetzt müsste Aurora Newstrike übernehmen ... also sogar noch Übernahmephantasie in Newstrike!
Meinungen?
Newstrike receives shareholder OK for CanniMed deal
2018-01-17 16:06 ET - News Release
An anonymous director reports
NEWSTRIKE ANNOUNCES SHAREHOLDER APPROVAL OF PLAN OF ARRANGEMENT WITH CANNIMED
[...]
Hinweis nach § 34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser dieses Beitrags kann Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n) halten. Entsprechende Beiträge stellen keine Kauf- oder Verkaufsempfehlungen dar.
Das Umtauschverhältnis scheint mir kurzfristig nicht relevant. Morgen gehts erstmal UP.
Das Umtauschverhältnis war seit November 2017 bekannt ... trotzdem gings auf CAD $ 3.30 im Hoch
Jetzt müsste Aurora Newstrike übernehmen ... also sogar noch Übernahmephantasie in Newstrike!
Meinungen?
Newstrike receives shareholder OK for CanniMed deal
2018-01-17 16:06 ET - News Release
An anonymous director reports
NEWSTRIKE ANNOUNCES SHAREHOLDER APPROVAL OF PLAN OF ARRANGEMENT WITH CANNIMED
[...]
Hinweis nach § 34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser dieses Beitrags kann Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n) halten. Entsprechende Beiträge stellen keine Kauf- oder Verkaufsempfehlungen dar.
Zuletzt bearbeitet von Paradiso am 17.01.2018, 23:28, insgesamt einmal bearbeitet
Hinweis nach §34b WpHG zur Begründung möglicher Interessenskonfl.: Der Verfasser von o.g. Beitrag kann Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n) halten.
TORONTO, ONTARIO -- (Marketwired) -- 01/17/18 -- Newstrike Resources Ltd. (TSX VENTURE: HIP) ("Newstrike" or the "Company") is pleased to announce that at an annual and special meeting of its shareholders held today (the "Meeting"), its shareholders overwhelmingly approved the previously announced proposed plan of arrangement (the "Plan of Arrangement") with CanniMed Therapeutics Inc. ("CanniMed"), pursuant to which CanniMed will acquire all of the outstanding common shares of Newstrike (the "Common Shares"). Of those votes cast with respect to the Plan of Arrangement, an aggregate of 271,880,416 Common Shares, representing approximately 99.40% of the votes cast by the shareholders at the Meeting or represented by proxy, were voted in support of the resolution. In addition, an aggregate of 239,517,680 Common Shares, representing approximately 99.30% of the votes cast by the shareholders at the meeting or represented by proxy excluding certain insiders, were voted in support of the resolution
http://www.finanznachrichten.de/nac....ent-with-cannimed-256.htmHinweis nach § 34 des WpHG zur Begründung möglicher Interessenskonflikte:
Meine Beiträge stellen weder Kauf- oder Verkaufsempfehlungen dar
Die grösste Entscheidung deines Lebens liegt darin dass du dein Leben ändern kannst,
indem du deine Geisteshaltung änderst (Albert Schweitzer)
Newstrike Announces Shareholder Approval of Plan of Arrangement with CanniMed
TORONTO, ONTARIO--(Marketwired - Jan. 17, 2018) - Newstrike Resources Ltd. (TSX VENTURE:HIP) ("Newstrike" or the "Company") is pleased to announce that at an annual and special meeting of its shareholders held today (the "Meeting"), its shareholders overwhelmingly approved the previously announced proposed plan of arrangement (the "Plan of Arrangement") with CanniMed Therapeutics Inc. ("CanniMed"), pursuant to which CanniMed will acquire all of the outstanding common shares of Newstrike (the "Common Shares"). Of those votes cast with respect to the Plan of Arrangement, an aggregate of 271,880,416 Common Shares, representing approximately 99.40% of the votes cast by the shareholders at the Meeting or represented by proxy, were voted in support of the resolution. In addition, an aggregate of 239,517,680 Common Shares, representing approximately 99.30% of the votes cast by the shareholders at the meeting or represented by proxy excluding certain insiders, were voted in support of the resolution.
In addition to the foregoing, all other matters voted upon at the Meeting by shareholders were approved, including the election of all nominated directors, the appointment of the Company's auditor, and the confirmation of Newstrike's existing stock option plan.
The Plan of Arrangement remains subject to approval of the shareholders of CanniMed at a special meeting of shareholders which is currently scheduled for Tuesday, January 23, 2018, court approval, applicable regulatory approvals, and the satisfaction of certain other closing conditions customary in transactions of this nature, as specified in the Company's management information circular dated December 12, 2017, available on SEDAR at www.sedar.com.
Risikohinweis / Disclaimer: Die hier genannten Instrumente stellen keine Anlageberatung und auch keine Aufforderung zum Kauf oder Verkauf von Wertpapieren dar. Ergänzend weise ich daraufhin, dass ich persönlich Positionen in den jeweiligen Gattungen halten und auch jederzeit auflösen kann.
steige nicht ganz durch bei der Speku ? die Newstrike Aktionäre haben ja nun zugestimmt je 1000 Aktien für 33 Cannimed zu tauschen. ( auf derzeitigem Niveau ja eher um die 0,60 € / 0N8 Aktie
sollte die Übernahme von Cannimed durch Aurora nun platzen, wäre die Speku als 0N8-Aktionär, dass der Cannimed Kurs stark ansteigt und man damit mehr für seine 0N8 Shares erhält oder liege ich da falsch ?
Newstrike Announces Shareholder Approval of Plan of Arrangement with CanniMed
TORONTO, ONTARIO--(Marketwired - Jan. 17, 2018) - Newstrike Resources Ltd. (TSX VENTURE:HIP) ("Newstrike" or the "Company") is pleased to announce that at an annual and special meeting of its shareholders held today (the "Meeting"), its shareholders overwhelmingly approved the previously announced proposed plan of arrangement (the "Plan of Arrangement") with CanniMed Therapeutics Inc. ("CanniMed"), pursuant to which CanniMed will acquire all of the outstanding common shares of Newstrike (the "Common Shares"). Of those votes cast with respect to the Plan of Arrangement, an aggregate of 271,880,416 Common Shares, representing approximately 99.40% of the votes cast by the shareholders at the Meeting or represented by proxy, were voted in support of the resolution. In addition, an aggregate of 239,517,680 Common Shares, representing approximately 99.30% of the votes cast by the shareholders at the meeting or represented by proxy excluding certain insiders, were voted in support of the resolution.
In addition to the foregoing, all other matters voted upon at the Meeting by shareholders were approved, including the election of all nominated directors, the appointment of the Company's auditor, and the confirmation of Newstrike's existing stock option plan.
The Plan of Arrangement remains subject to approval of the shareholders of CanniMed at a special meeting of shareholders which is currently scheduled for Tuesday, January 23, 2018, court approval, applicable regulatory approvals, and the satisfaction of certain other closing conditions customary in transactions of this nature, as specified in the Company's management information circular dated December 12, 2017, available on SEDAR at www.sedar.com.
steige nicht ganz durch bei der Speku ? die Newstrike Aktionäre haben ja nun zugestimmt je 1000 Aktien für 33 Cannimed zu tauschen. ( auf derzeitigem Niveau ja eher um die 0,60 € / 0N8 Aktie
sollte die Übernahme von Cannimed durch Aurora nun platzen, wäre die Speku als 0N8-Aktionär, dass der Cannimed Kurs stark ansteigt und man damit mehr für seine 0N8 Shares erhält oder liege ich da falsch ?
[...]
Hinweis nach § 34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser dieses Beitrags hält jetzt oder zukünftig Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n). Entsprechende Beiträge stellen keine Kauf- oder Verkaufsempfehlungen dar.
Newstrike Fehleinschätzung! Hab da was falsch interpretiert.Hinweis nach § 34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser dieses Beitrags kann Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n) halten. Entsprechende Beiträge stellen keine Kauf- oder Verkaufsempfehlungen dar.
steige nicht ganz durch bei der Speku ? die Newstrike Aktionäre haben ja nun zugestimmt je 1000 Aktien für 33 Cannimed zu tauschen. ( auf derzeitigem Niveau ja eher um die 0,60 € / 0N8 Aktie
sollte die Übernahme von Cannimed durch Aurora nun platzen, wäre die Speku als 0N8-Aktionär, dass der Cannimed Kurs stark ansteigt und man damit mehr für seine 0N8 Shares erhält oder liege ich da falsch ?
[...]
Marantha!
Homo proponit sed deus disponit - Es ist ein langer Weg zum Whisky-Experten - aber es ist eine schöne Zeit dahin! - gemäß § 34 WpHG darf der Autor zu jederzeit Short- oder Long-Positionen in der/den behandelte(n) Aktie(n) halten.
Jetzt müsste Aurora Newstrike übernehmen ... also sogar noch Übernahmephantasie in Newstrike!
Meinungen?
Newstrike receives shareholder OK for CanniMed deal
2018-01-17 16:06 ET - News Release
An anonymous director reports
NEWSTRIKE ANNOUNCES SHAREHOLDER APPROVAL OF PLAN OF ARRANGEMENT WITH CANNIMED
[...]
Hinweis nach § 34 WpHG zur Begründung möglicher Interessenskonflikte: Der Verfasser dieses Beitrags hält jetzt oder zukünftig Short- und/oder Long-Positionen in der/den behandelte(n) Aktie(n).